H. Hausenblas

Molecular Nutrition & Food Research · 2001–2020

A researcher in the Science corpus: 11 papers; trusts 0 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Whom H. Hausenblas trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Rosenthal

Who trusts H. Hausenblas overall

  1. Martin S. Hagger
  2. V. Costarelli
  3. Kam Hung
  4. Kyle J. Miller
  5. Howard K. Hall
  6. Anne C. Muscat
  7. D. Stamou
  8. Nikos L. D. Chatzisarantis

Papers from H. Hausenblas's perspective

Ordered by how strongly the researchers H. Hausenblas trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Therapeutic potential of resveratrol: the in vivo evidence (Nature reviews. Drug discovery)
  2. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. (Cell)
  3. HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS (Drug Metabolism And Disposition)
  4. A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice (PLoS ONE)
  5. SIRT1 transgenic mice show phenotypes resembling calorie restriction (Aging Cell)
  6. WRITING META-ANALYTIC REVIEWS
  7. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. (Clinical Biochemistry)
  8. Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient Mice (Diabetes)
  9. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. (Cell Metabolism)
  10. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. (British Journal of Nutrition)

Their papers